(2R,6R)-Hydroxynorketamine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for (2R,6R)-Hydroxynorketamine, covering 2024-06-06 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression [Phase 2]